AI-driven MRI biomarker for triple-class HER2 expression classification in breast cancer: a large-scale multicenter

Chinting Wong1,2, Qi Yang3, Yanting Liang1,2

  • 1Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.

Breast Cancer Research : BCR
|September 27, 2025
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos